Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ERYTHROPOIETIN VARIANTS
Document Type and Number:
WIPO Patent Application WO2006120030
Kind Code:
A8
Abstract:
The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammtion, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.

More Like This:
JP4547153Diagnostic methods for protein profiling
JP2002125676NEW HEMOLYTICALLY ACTIVE PROTEIN AND GENE ENCODING THE PROTEIN
WO/2002/020580A NOVEL POLYPEPTIDE-HUMAN TNFR/NGFR PROTEIN 15 THAT CONTAINS CYTOCHROME C STRUCTURAL DOMAIN AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
Inventors:
MEISEL ANDREAS (DE)
PRILLER JOSEF (DE)
BONNAS CHRISTEL (DE)
DIRNAGL ULRICH (DE)
Application Number:
PCT/EP2006/004564
Publication Date:
December 28, 2006
Filing Date:
May 15, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHARITE UNIVERSITAETSMEDIZIN (DE)
MEISEL ANDREAS (DE)
PRILLER JOSEF (DE)
BONNAS CHRISTEL (DE)
DIRNAGL ULRICH (DE)
International Classes:
C07K14/435
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: HEAT EXCHANGER WITH VARYING CROSS SECTIONAL AREA OF CONDUITS

Next Patent: WIND FARM POWER CONTROL SYSTEM